Bandaríkin - enska - NLM (National Library of Medicine)

humco holding group, inc. - magnesium hydroxide (unii: nbz3qy004s) (magnesium cation - unii:t6v3lhy838) - magnesium hydroxide 80 mg in 1 ml - antacid/saline laxative as an antacid: helps relieve acid ingestion, heartburn and sour stomach. as a laxative: for the temporary relief of occasional constipation. bowel movement is generally produced in 1.2 to 6 hours. abdominal pain, nausea, vomiting, kidney desease, are on a magnesium restricted diet, a sudden change in bowel habits lasting longer than 14 days, if you are taking prescription drugs. antacids may interact with certain prescription drugs. if you have rectal bleeding or have no bowel movement after using this product. this could be signs of a serious codition, if you need to use a laxative for more than one week. frequent or prolonged use may result in the dependence on laxatives.

Bandaríkin - enska - NLM (National Library of Medicine)

westminster pharmaceuticals, llc - magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), calcium (unii: sy7q814vup) (calcium - unii:sy7q814vup) - magnesium cation 251 mg

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

blackmores ltd - pyridoxine hydrochloride, quantity: 50 mg (equivalent: pyridoxine, qty 41.1 mg); manganese amino acid chelate, quantity: 40 mg (equivalent: manganese, qty 4 mg); calcium ascorbate, quantity: 250 mg; colecalciferol, quantity: 0.0025 mg; heavy magnesium oxide, quantity: 440 mg (equivalent: magnesium, qty 265.3 mg); magnesium phosphate pentahydrate, quantity: 175 mg (equivalent: magnesium, qty 36.2 mg) - tablet, film coated - excipient ingredients: magnesium stearate; calcium hydrogen phosphate dihydrate; titanium dioxide; microcrystalline cellulose; soy polysaccharide; tapioca starch; hypromellose; macrogol 400; purified talc; carnauba wax; maize starch; silicon dioxide; dl-alpha-tocopherol; hydrolysed gelatin; hydrogenated soya oil; sucrose; colour - sufficient magnesium helps all muscles in the body to function optimally.

Bandaríkin - enska - NLM (National Library of Medicine)

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate in water for injection is indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively.  when used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant.  however, other effective drugs are available for this purpose. intravenous magnesium should not be given to mothers with toxemia of pregnancy during the two hours preceding delivery.

Bandaríkin - enska - NLM (National Library of Medicine)

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate in 5% dextrose injection, usp is indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively.  when used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant.  however, other effective drugs are available for this purpose. intravenous magnesium should not be given to mothers with toxemia of pregnancy during the two hours preceding delivery.

Bandaríkin - enska - NLM (National Library of Medicine)

allegiant health - magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838) - relieves - acid indigestion - upset stomach

Malta - enska - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - aluminium hydroxide, magnesium hydroxide - oral suspension - magnesium hydroxide 400 mg aluminium hydroxide 460 mg - drugs for acid related disorders

Bandaríkin - enska - NLM (National Library of Medicine)

spirit pharmaceuticals llc - magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838) - relieves - acid indigestion - upset stomach

Bandaríkin - enska - NLM (National Library of Medicine)

gland pharma limited - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate in water for injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. when used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. however, other effective drugs are available for this purpose. intravenous magnesium should not be given to mothers with toxemia of pregnancy during the two hours preceding delivery.

Bandaríkin - enska - NLM (National Library of Medicine)

b. braun medical inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate in 5% dextrose injection is indicated for: - prevention of eclampsia in patients with preeclampsia - treatment of seizures and prevention of recurrent seizures in patients with eclampsia magnesium sulfate in 5% dextrose injection is contraindicated in patients: - with heart block or myocardial damage - in diabetic coma - with myasthenia gravis [see warnings and precautions (5.6)] risk summary magnesium sulfate in 5% dextrose injection is indicated in pregnant women for the prevention of eclampsia in women with preeclampsia and the treatment of seizures and prevention of recurrent seizures in women with eclampsia. fetal, neonatal, and maternal risks are discussed throughout the labeling. clinical considerations labor or delivery: magnesium sulfate in 5% dextrose injection is not approved for the treatment of pre-term labor. administration of magnesium sulfate in 5% dextrose injection to pregnant women longer than 5 to 7 days may lead to hypocalcemia and bone abnormalities in the developing fe